Singapore markets open in 5 hours 52 minutes

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.25+0.10 (+1.40%)
As of 03:08PM EDT. Market open.
Full screen
Loading interactive chart…
  • GlobeNewswire

    ORLADEYO® (berotralstat) Approved in Peru

    RESEARCH TRIANGLE PARK, N.C., July 09, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the General Directorate of Medicines, Supplies and Drugs (DIGEMID) in Peru has granted approval for oral, once-daily ORLADEYO® (berotralstat) for the prophylaxis of hereditary angioedema (HAE) attacks in adults and pediatric patients 12 years of age or older. “We continue to work alongside our partner, Pint Pharma, to bring ORLADEYO to people living with HAE who are

  • GlobeNewswire

    BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    RESEARCH TRIANGLE PARK, N.C., July 02, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted five newly-hired employees stock options to purchase an aggregate of 46,850 shares, and restricted stock units (RSUs) covering an aggregate of 19,435 shares, of BioCryst common stock. The options and RSUs were granted as of June 28, 2024, as inducements material to each employee entering into employm

  • Simply Wall St.

    BioCryst Pharmaceuticals Insiders Added US$1.05m Of Stock To Their Holdings

    It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...